Fiber fix: new supplement aims to stop Chemo-Induced diarrhea

NCT ID NCT05296681

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a high-fiber product called NBT-NM108 in 42 people with advanced colon cancer who are receiving a chemotherapy drug called irinotecan. The goal is to see if the supplement can reduce or prevent the severe diarrhea that often comes with this treatment. By helping the gut stay healthy, researchers hope patients can better tolerate their chemotherapy and have fewer side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Community Medical Center

    RECRUITING

    Toms River, New Jersey, 08753, United States

  • Cooperman Barnabas Medical Center

    RECRUITING

    Livingston, New Jersey, 07039, United States

  • Monmouth Medical Center

    RECRUITING

    Lakewood, New Jersey, 08701, United States

  • Newark Beth Israel Medical Center

    RECRUITING

    Newark, New Jersey, 07112, United States

  • RWJBarnabas Health - Monmouth Medical Center Southern Campus

    RECRUITING

    Lakewood, New Jersey, 08701, United States

  • Robert Wood Johnson University Hospital

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

  • Robert Wood Johnson University Hospital, Hamilton

    RECRUITING

    Hamilton, New Jersey, 08690, United States

  • Robert Wood Johnson University Hospital, Somerset

    RECRUITING

    Somerville, New Jersey, 08876, United States

  • Rutgers Cancer Institute of New Jersey

    RECRUITING

    New Brunswick, New Jersey, 08903, United States

  • The Cancer Center

    RECRUITING

    Newark, New Jersey, 07103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.